Literature DB >> 14711397

The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors.

Hu Li1, Jianzhong Huang, Xinhe Jiang, Mark Seefeld, Michael McQueney, Ricardo Macarron.   

Abstract

Undecaprenyl pyrophosphate synthase (UPPS) catalyzes the consecutive condensation of 8 molecules of isopentenyl pyrophosphate with farnesyl pyrophosphate to yield C55-undecaprenyl pyrophosphate, which is required for bacterial cell wall synthesis. UPPS is found in both gram-positive and gram-negative bacteria, and based on the differences between bacterial variants of UPPS and their human counterpart, dolicopyrophosphate synthase, it was identified as an attractive antibacterial target. An assay, which monitors the release of Pi by coupling the UPPS catalyzed reaction with inorganic pyrophosphatase, was employed to conduct an HTS campaign using an inhouse collection of compounds. A direct assay measuring the incorporation of 14C-IPP (isopentenyl pyrophosphate) was used as a secondary assay to evaluate the high-throughput screening (HTS) hits. From the HTS campaign, a few classes of UPPS inhibitors were identified. During the process of hit evaluation by the direct assay, the authors observed that Triton, an essential factor for the enzyme activity and accurate formation of the natural product, dramatically altered the inhibitory activity of a particular class of compounds. Above its critical micellar concentration (CMC), Triton abolished the inhibitory activity of these compounds. Further research will be required to establish the biophysical phenomenon that causes this effect. Meanwhile, it can be speculated that Triton (and other detergents) above CMC may hinder the identification in screening compounds of certain classes of hits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711397     DOI: 10.1177/1087057103258185

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  10 in total

1.  Tuning the production of variable length, fluorescent polyisoprenoids using surfactant-controlled enzymatic synthesis.

Authors:  Jerry M Troutman; Katelyn M Erickson; Phillip M Scott; Joseph M Hazel; Christina D Martinez; Samantha Dodbele
Journal:  Biochemistry       Date:  2015-04-29       Impact factor: 3.162

2.  Reducing the Level of Undecaprenyl Pyrophosphate Synthase Has Complex Effects on Susceptibility to Cell Wall Antibiotics.

Authors:  Yong Heon Lee; John D Helmann
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

3.  Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.

Authors:  Lac V Lee; Brian Granda; Karl Dean; Jianshi Tao; Eugene Liu; Rui Zhang; Stefan Peukert; Sompong Wattanasin; Xiaoling Xie; Neil S Ryder; Ruben Tommasi; Gejing Deng
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

4.  Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases.

Authors:  Rey-Ting Guo; Rong Cao; Po-Huang Liang; Tzu-Ping Ko; Tao-Hsin Chang; Michael P Hudock; Wen-Yih Jeng; Cammy K-M Chen; Yonghui Zhang; Yongcheng Song; Chih-Jung Kuo; Fenglin Yin; Eric Oldfield; Andrew H-J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

5.  Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target.

Authors:  William Sinko; César de Oliveira; Sarah Williams; Adam Van Wynsberghe; Jacob D Durrant; Rong Cao; Eric Oldfield; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-03-29       Impact factor: 2.817

6.  Species differences in alternative substrate utilization by the antibacterial target undecaprenyl pyrophosphate synthase.

Authors:  Samantha Dodbele; Christina D Martinez; Jerry M Troutman
Journal:  Biochemistry       Date:  2014-07-18       Impact factor: 3.162

Review 7.  Peptidoglycan pathways: there are still more!

Authors:  Ahmed M Helal; Ahmed M Sayed; Mariam Omara; Mohamed M Elsebaei; Abdelrahman S Mayhoub
Journal:  RSC Adv       Date:  2019-09-09       Impact factor: 4.036

8.  Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases.

Authors:  Chih-Jung Kuo; Rey-Ting Guo; I-Lin Lu; Hun-Ge Liu; Su-Ying Wu; Tzu-Ping Ko; Andrew H-J Wang; Po-Huang Liang
Journal:  J Biomed Biotechnol       Date:  2008

9.  Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads.

Authors:  William Sinko; Yang Wang; Wei Zhu; Yonghui Zhang; Ferran Feixas; Courtney L Cox; Douglas A Mitchell; Eric Oldfield; J Andrew McCammon
Journal:  J Med Chem       Date:  2014-06-24       Impact factor: 7.446

Review 10.  Anti-infectious agents against MRSA.

Authors:  Nobuhiro Koyama; Junji Inokoshi; Hiroshi Tomoda
Journal:  Molecules       Date:  2012-12-24       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.